Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lannergård

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|August 28, 2003
Correlations between serum amyloid A protein and C-reactive protein in infectious diseasesA Lannergård, A Larsson, P Kragsbjerg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 31, 2008
Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infectionsA Lannergård, A Larsson, G Friman, et al.
Scandinavian Journal of Medicine & Science in Sports|November 7, 2001
Immune function in Swedish élite orienteersA Lannergård, J Fohlman, L Wesslén, et al.
Harm Reduction Journal|June 16, 2023
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, SwedenE Kågström, A Lannergård, J El Khosht, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Clinical and Laboratory Investigation|August 28, 2003
Correlations between serum amyloid A protein and C-reactive protein in infectious diseasesA Lannergård, A Larsson, P Kragsbjerg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 31, 2008
Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infectionsA Lannergård, A Larsson, G Friman, et al.
Scandinavian Journal of Medicine & Science in Sports|November 7, 2001
Immune function in Swedish élite orienteersA Lannergård, J Fohlman, L Wesslén, et al.
Harm Reduction Journal|June 16, 2023
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, SwedenE Kågström, A Lannergård, J El Khosht, et al.
Pageof 1